Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 1,676 shares at $238.93 ($400K) on 2024-02-15, disclosed to the SEC on 2024-02-20.
Seasonal sale ($400k) by EVP, Corporate Strategy & Develop — this insider has traded CRL in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $238.93 | 838 | $200K | 50.0% |
| 2 | $238.93 | 838 | $200K | 50.0% |
| Total | $238.93 avg | 1,676 | $400K | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |